PeproTech Inc.
Originally published online as doi:10.1189/jlb.0106035 on April 13, 2006

Published online before print April 13, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0106035v1
79/6/1369    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cronshaw, D. G.
Right arrow Articles by Ward, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cronshaw, D. G.
Right arrow Articles by Ward, S. G.
(Journal of Leukocyte Biology. 2006;79:1369-1380.)
© 2006 by Society for Leukocyte Biology

Evidence that phospholipase C-dependent, calcium-independent mechanisms are required for directional migration of T lymphocytes in response to the CCR4 ligands CCL17 and CCL22

Darran G. Cronshaw*, Andreas Kouroumalis*, Richard Parry*, Adam Webb*, Zarin Brown{dagger} and Stephen G. Ward*,1

* Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Avon, United Kingdom; and
{dagger} Novartis Horsham Research Centre, West Sussex, United Kingdom

1Correspondence: Department of Pharmacy & Pharmacology, University of Bath, Claverton Down, Bath, Avon, UK BA2 7AY. E-mail: S.G.Ward{at}bath.ac.uk

Macrophage-derived chemokine [CC chemokine ligand 22 (CCL22)] and thymus- and activation-regulated chemokine (CCL17) mediate cellular effects, principally by binding to their receptor CC chemokine receptor 4 (CCR4) and together, constitute a multifunctional chemokine/receptor system with homeostatic and inflammatory roles within the body. This study demonstrates that CCL22 and CCL17 stimulate pertussis toxin-sensitive elevation of intracellular calcium in the CEM leukemic T cell line and human peripheral blood-derived T helper type 2 (Th2) cells. Inhibition of phospholipase C (PLC) resulted in the abrogation of chemokine-mediated calcium mobilization. Chemokine-stimulated calcium responses were also abrogated completely by the inhibition of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] receptor-mediated calcium release. Chemotactic responses of CEM and human Th2 cells to CCL17 and CCL22 were similarly abrogated by inhibition of PLC and inhibition of novel, Ca2+-independent/diacylglycerol-dependent protein kinase C (PKC) isoforms. Inhibition of Ins(1,4,5)P3 receptor-mediated calcium release from intracellular stores had no effect on chemotactic responses to CCR4 ligands. Taken together, this study provides compelling evidence of an important role for PLC and diacylglycerol-dependent effector mechanisms (most likely involving novel PKC isoforms) in CCL17- and CCL22-stimulated, directional cell migration. In this regard, CCL22 stimulates phosphatidylinositol-3 kinase-independent phosphorylation of the novel {delta} isoform of PKC at threonine 505, situated within its activation loop—an event closely associated with increased catalytic activity.

Key Words: chemokines • signaling • chemotaxis • PKC




This article has been cited by other articles:


Home page
JCBHome page
J.-J. Hao, Y. Liu, M. Kruhlak, K. E. Debell, B. L. Rellahan, and S. Shaw
Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane
J. Cell Biol., February 9, 2009; 184(3): 451 - 462.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. Galimberti, C. Fenoglio, C. Comi, D. Scalabrini, M. De Riz, M. Leone, E. Venturelli, F. Cortini, M. Piola, F. Monaco, et al.
MDC/CCL22 intrathecal levels in patients with multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 547 - 549.
[Abstract] [PDF]


Home page
JCBHome page
R. A. Lacalle, R. M. Peregil, J. P. Albar, E. Merino, C. Martinez-A, I. Merida, and S. Manes
Type I phosphatidylinositol 4-phosphate 5-kinase controls neutrophil polarity and directional movement
J. Cell Biol., December 31, 2007; 179(7): 1539 - 1553.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Patrussi, C. Ulivieri, O. M. Lucherini, S. R. Paccani, A. Gamberucci, L. Lanfrancone, P. G. Pelicci, and C. T. Baldari
p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells
Blood, September 15, 2007; 110(6): 1730 - 1738.
[Abstract] [Full Text] [PDF]